BlackRock, Inc.Added
- Quarter
- Jun 30, 2026
- Shares held
- 8,218,151
- Share change
- +1,047,283
- Value change
- +$73.28M
ALUMIS INC.
/ ALMSNMSWhat is ALMS stock?
ALMS is the U.S. stock ticker for ALUMIS INC..
As of 2026-09-13: price $9.18; market cap $1.16B; 12 recent 13F changes.
$9.18-7.27%
Yahoo Finance ↗·Updated 09/13/2026, 08:05 AM UTC
- Current price
- $9.18
- Market cap
- $1.16B
- Latest earnings date
- Unavailable
- Data status
- Partial
Yahoo Finance
SEC EDGAR weighted-average basic shares × Yahoo Finance price
SEC EDGAR
earnings
Source: Yahoo Finance ↗SEC EDGAR weighted-average basic shares × Yahoo Finance price ↗Updated: 09/13/2026, 08:05 AM UTC
Price change after earnings
Unavailable
Recent insider transactions
Unavailable
13F institutional changes
| Quarter | Institution | Type | Shares held | Share change | Value change | Source |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | BlackRock, Inc. | Added | 8,218,151 | +1,047,283 | +$73.28M | SEC 13F ↗ |
| Jun 30, 2026 | FMR LLC / Fidelity | Added | 6,769,170 | +5,795,388 | +$169.03M | SEC 13F ↗ |
| Jun 30, 2026 | Vanguard Capital Management LLC | Added | 4,215,703 | +183,437 | +$29.8M | SEC 13F ↗ |
| Mar 31, 2026 | UBS Group AG | Added | 3,054,865 | +2,940,869 | +$64.79M | SEC 13F ↗ |
| Jun 30, 2026 | State Street Corp | Added | 2,187,266 | +385,454 | +$21.86M | SEC 13F ↗ |
| Jun 30, 2026 | Geode Capital Management, LLC | Added | 2,168,517 | +250,102 | +$18.76M | SEC 13F ↗ |
| Mar 31, 2026 | Janus Henderson Group PLC | Added | 2,124,408 | +29,331 | +$646.02K | SEC 13F ↗ |
| Mar 31, 2026 | Invesco Ltd. | Added | 1,511,537 | +1,089,673 | +$24.01M | SEC 13F ↗ |
| Jun 30, 2026 | JPMorgan Chase & Co. | New position | 969,617 | +108,042 | +$8.99M | SEC 13F ↗ |
| Jun 30, 2026 | Vanguard Portfolio Management LLC | Added | 921,211 | +208,603 | +$10.22M | SEC 13F ↗ |
| Mar 31, 2026 | Marshall Wace, LLP | Added | 1,172,749 | +799,856 | +$17.62M | SEC 13F ↗ |
| Mar 31, 2026 | Goldman Sachs Group Inc. | Added | 718,040 | +290,889 | +$6.41M | SEC 13F ↗ |
FMR LLC / FidelityAdded
- Quarter
- Jun 30, 2026
- Shares held
- 6,769,170
- Share change
- +5,795,388
- Value change
- +$169.03M
- Quarter
- Jun 30, 2026
- Shares held
- 4,215,703
- Share change
- +183,437
- Value change
- +$29.8M
UBS Group AGAdded
- Quarter
- Mar 31, 2026
- Shares held
- 3,054,865
- Share change
- +2,940,869
- Value change
- +$64.79M
State Street CorpAdded
- Quarter
- Jun 30, 2026
- Shares held
- 2,187,266
- Share change
- +385,454
- Value change
- +$21.86M
- Quarter
- Jun 30, 2026
- Shares held
- 2,168,517
- Share change
- +250,102
- Value change
- +$18.76M
- Quarter
- Mar 31, 2026
- Shares held
- 2,124,408
- Share change
- +29,331
- Value change
- +$646.02K
Invesco Ltd.Added
- Quarter
- Mar 31, 2026
- Shares held
- 1,511,537
- Share change
- +1,089,673
- Value change
- +$24.01M
JPMorgan Chase & Co.New position
- Quarter
- Jun 30, 2026
- Shares held
- 969,617
- Share change
- +108,042
- Value change
- +$8.99M
- Quarter
- Jun 30, 2026
- Shares held
- 921,211
- Share change
- +208,603
- Value change
- +$10.22M
Marshall Wace, LLPAdded
- Quarter
- Mar 31, 2026
- Shares held
- 1,172,749
- Share change
- +799,856
- Value change
- +$17.62M
- Quarter
- Mar 31, 2026
- Shares held
- 718,040
- Share change
- +290,889
- Value change
- +$6.41M
Share counts are derived from reported value divided by the filing price and are rounded for display.
Key people timeline
- Martin Babler
Envudeucitinib’s Phase 3 clinical validation in PsO, reinforced by our ONWARD3 long-term data, demonstrates the power of maximal TYK2 inhibition in IL-23/IL-17-driven diseases, and our anticipated Phase 2b LUMUS readout in SLE may substantiate its role in IFN-driven diseases -- potentially unlocking broader potential of our TYK2 franchise
ALUMIS INC. (ALMS) - Martin Babler
Alumis delivered a focused and productive first quarter, building on the Phase 3 clinical validation of envudeucitinib in moderate - to - severe plaque psoriasis and reinforcing the differentiated potential of maximal TYK2 inhibition
ALUMIS INC. (ALMS)
Related data
Data sources and methodology
Prices use Yahoo Finance, earnings dates use Nasdaq, and company reference data prefers Polygon.io. When Polygon market cap is unavailable, the page derives it from the latest SEC shares outstanding multiplied by the Yahoo price. Insider and institutional records link to SEC EDGAR, and missing values are never invented.
Updated: 09/13/2026, 08:05 AM UTC
Collection, calculation and correction policy- Yahoo Finance
- 09/13/2026, 08:05 AM UTC
- SEC EDGAR weighted-average basic shares × Yahoo Finance price
- 08/13/2026, 12:00 AM UTC
- Nasdaq
- Unavailable
- SEC Form 4
- Unavailable
- SEC 13F
- 08/07/2026, 05:05 PM UTC
- Statements / public records
- 08/13/2026, 08:20 PM UTC